6/17/24 07:20 | 6/15/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 21 | 25 | 106 | D | | | | | | | | | | | | | | |
12/27/23 17:00 | 12/22/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | | P.d | 17 | 0.7100 | 0 | 24 | 11 | 252 | D | | | | | | | | | | | | | | |
8/23/23 09:28 | 8/21/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | | P | 12 | 0.5892 | 0 | 20 | 9 | 239 | D | | | | | | | | | | | | | | |
8/7/23 16:05 | 8/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 16 | 23 | 85 | D | | | | | | | | | | | | | | |
11/15/22 16:07 | 11/14/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | | P | 28 | 0.5692 | 0 | 50 | 33 | 200 | M | | | | | | | | | | | | | | |
7/25/22 17:16 | 7/21/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | | P | 33 | 1.68 | 0 | 19 | 14 | 160 | D | | | | | | | | | | | | | | |
6/16/22 07:36 | 6/14/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 14 | 27 | 69 | D | | | | | | | | | | | | | | |
1/24/22 16:15 | 1/18/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | | P | 8 | 2.80 | 0 | 3 | 2 | 134 | I | | | | | | | | | | | | | | |
6/10/21 07:42 | 6/9/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 13 | 30 | 55 | D | | | | | | | | | | | | | | |
6/8/21 07:27 | 6/5/21 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 6 | 17 | 42 | D | | | | | | | | | | | | | | |
8/13/20 16:12 | 8/11/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 8 | 28 | 36 | D | | | | | | | | | | | | | | |
6/15/20 07:34 | 6/11/20 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 18 | 170 | 28 | D | | | | | | | | | | | | | | |
5/20/19 07:13 | 5/16/19 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 3 | 37 | 10 | D | | | | | | | | | | | | | | |
9/5/18 16:09 | 9/3/18 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Lieberman Gerald M | L3 | D | | M.d | 0 | 0.00 | 0 | 2 | 40 | 8 | D | | | | | | | | | | | | | | |